Skip to content

Research in Acute appenDIcitis and mAgnetic resonaNCE imaging.

Research in Acute appenDIcitis and mAgnetic resonaNCE imaging.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27091
Enrollment
100
Registered
2009-02-06
Start date
2009-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute appendicitis

Interventions

1. Ultra Sound (US)
2. Magnetic Resonance Imaging (MRI).

Sponsors

MCA Alkmaar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pediatric patients (4-18 years of age) with suspected appendicitis defined as right lower abdominal quadrant pain with or without elevation of CRP; 2. Patients, or a legal representative, must be able to give informed consent, and the consent must be obtained prior to the MR Imaging.

Exclusion criteria

Exclusion criteria: 1. Abdominal surgery in the 6 weeks prior to inclusion; 2. Contra-indication for undergoing MRI, for example presence of a pacemaker or cardioversion device; 3. A psychiatric, addictive, or any disorder that compromises ability to give truly informed consent for participation in this study.

Design outcomes

Primary

MeasureTime frame
Primary outcome measures are the sensitivity, specificity, positive and negative predictive value and inter observer agreement of MRI in diagnosing acute appendicitis as compared to the reference standard. The MRI findings will be compared to the findings at imaging of the standard diagnostic work-up that preceded MRI (US). The diagnostic value of specific MRI characteristics for appendicitis will be calculated.

Secondary

MeasureTime frame
Secondary outcome measures are the acceptance of MRI as compared to US by a questionary.

Contacts

Public ContactM.E. Thieme

Medical Center Alkmaar P.O.Box 500

m.thieme@mca.nl+31(0)72 5483419

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)